drugset / Trial / NCT02291549

S8 Sinus Implant in Chronic Sinusitis Patients With Recurrent Nasal Polyps

NCT02291549

Phase 3 Completed 300 enrolled Intersect ENT
RandomizedParallel-groupDouble-blindTreatment

Summary

The RESOLVE II Study is a randomized, single-blind, parallel arm, concurrently controlled, multicenter study with 300 chronic sinusitis patients who had prior endoscopic sinus surgery but present with recurrent sinus obstruction.

Timeline

Start
2014-12
Primary completion
2016-10
Completion
2016-10

Drugs

EvaluationDrugModalityDoseRoute
Background Mometasone furoate Other / unclassified 1350 ug Other
Background Mometasone furoate Other / unclassified 200 ug Intranasal